Can low 25-hydroxyvitamin D despite supplementation reflect inadequate effective exposure?

A low 25-hydroxyvitamin D [25(OH)D] result despite reported supplementation is compatible with inadequate effective exposure, particularly in an older adult, but the most actionable determinants are dose, regular use, and adequate time on treatment.

Clinical evidence

• Oral vitamin D3 generally raises serum 25(OH)D in a dose-dependent, though curvilinear and person-variable, fashion. Thus, a dose that is too low for the individual, intermittent use, or insufficient treatment duration can leave the measured level low.
• Biochemical response should usually be judged after sustained use. Adult management guidance supports rechecking 25(OH)D after approximately 8–12 weeks when deficiency persists or adherence is uncertain; older repletion approaches commonly used an 8-week treatment course before transition to maintenance.
• A low value measured earlier than this, or following irregular intake, need not indicate that supplementation is ineffective.

Formulation and food timing

• Food effects are not uniform. In a randomized trial of adults aged 50–69 receiving 50,000 IU vitamin D3, taking the dose with meals changed the short-term rise in vitamin D3 itself but did not alter 25(OH)D at 30 or 90 days; a meal was not required for absorption.
• An oily preparation likewise produced similar responses fasting and with a high-fat breakfast. However, a small 14-day trial found higher 25(OH)D with a high-fat than low-fat meal. These findings support food and formulation as possible modifiers, not universal explanations.

Bottom line

• Persistently low 25(OH)D during supplementation most strongly points to insufficient dose, inconsistent intake, or too short a treatment interval. Formulation and whether doses are taken with food can contribute in some circumstances, but evidence for a consistent clinically important effect is mixed.